ISSCR News
ISSCR Comments on New Biomedical Technology Regulations in China
In response to draft regulations in China on gene editing and other potentially risky biomedical technologies, the ISSCR has submitted comments to the the country's National Health Commission Medical and Medical Administration Bureau.
ISSCR Applauds New Japanese Rules Allowing Human-to-Animal Chimeric Embryo Research
The ISSCR supports research using human-animal chimeras conducted under appropriate review and oversight (ISSCR Guidelines Recommendation 2.1.5) and applauds the new Japanese rules enabling research on chimeric embryos. Research involving human-animal chimeras has led to increased understanding of human development and biology, with implications that have the potential to significantly impact human health.
Advocating for Science and Research
Scientists play a critical role in advocating for research that is advancing healthcare and biomedicine…
Standing Up for Scientific Research
The ISSCR’s support for stem cell science and the field is central to our mission, and we speak up for policies around the world that allow our work to continue and thrive. We also provide background and current understanding about stem cell science to inform decision makers about key issues affecting science and health.
ISSCR Testimony in U.S. Congress Regarding Need for Fetal Tissue Research
In written and oral testimony before the U.S. House of Representatives Oversight and Government Reform Committee today, former ISSCR president Sally Temple describes fetal tissue research as essential in studying and developing therapies for cancer, HIV, Zika, tuberculous, and other devastating diseases.
Receive ISSCR Press Releases
Sign up be a part of ISSCR’s media list. Media Contact: Kym Kilbourne, Director of Media and Strategic Communications
Subscribe to ISSCR News.
Each month, ISSCR delivers scientific, policy, and community to your inbox .